Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $13.08 in the prior trading day, DENTSPLY Sirona Inc (NASDAQ: XRAY) closed at $12.55, down -4.05%. In other words, the price has decreased by -$4.05 from its previous closing price. On the day, 3.11 million shares were traded. XRAY stock price reached its highest trading level at $12.945 during the session, while it also had its lowest trading level at $12.485.
Ratios:
Our goal is to gain a better understanding of XRAY by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.20 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.90. For the most recent quarter (mrq), Quick Ratio is recorded 0.74 and its Current Ratio is at 1.10. In the meantime, Its Debt-to-Equity ratio is 1.17 whereas as Long-Term Debt/Eq ratio is at 0.86.
On February 14, 2025, Wells Fargo started tracking the stock assigning a Equal Weight rating and target price of $20.Wells Fargo initiated its Equal Weight rating on February 14, 2025, with a $20 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 03 ’25 when LUCIER GREGORY T bought 15,142 shares for $16.51 per share. The transaction valued at 249,994 led to the insider holds 81,971 shares of the business.
Coleman Glenn bought 15,759 shares of XRAY for $311,240 on Jan 27 ’25. On Nov 18 ’24, another insider, LUCIER GREGORY T, who serves as the Director of the company, bought 5,000 shares for $18.37 each. As a result, the insider paid 91,850 and bolstered with 71,730 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XRAY now has a Market Capitalization of 2501127168 and an Enterprise Value of 4494349312. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.66 while its Price-to-Book (P/B) ratio in mrq is 1.28. Its current Enterprise Value per Revenue stands at 1.185 whereas that against EBITDA is 7.871.
Stock Price History:
The Beta on a monthly basis for XRAY is 0.96, which has changed by -0.5866271 over the last 52 weeks, in comparison to a change of 0.07455289 over the same period for the S&P500. Over the past 52 weeks, XRAY has reached a high of $31.75, while it has fallen to a 52-week low of $12.16. The 50-Day Moving Average of the stock is -22.60%, while the 200-Day Moving Average is calculated to be -40.56%.
Shares Statistics:
The stock has traded on average 2.97M shares per day over the past 3-months and 3770270 shares per day over the last 10 days, according to various share statistics. A total of 198.80M shares are outstanding, with a floating share count of 197.96M. Insiders hold about 0.67% of the company’s shares, while institutions hold 102.48% stake in the company. Shares short for XRAY as of 1743379200 were 10781052 with a Short Ratio of 3.62, compared to 1740700800 on 8062722. Therefore, it implies a Short% of Shares Outstanding of 10781052 and a Short% of Float of 6.23.
Dividends & Splits
In the trailing 12 months, XRAY’s forward annual dividend rate was 0.64, compared to 0.64 this year. Against a Trailing Annual Dividend Yield of 0.04892966The stock’s 5-year Average Dividend Yield is 1.46.
